Preliminary Report on the Treatment of Recurrent Herpes simplex with Poliomyelitis Vaccine (Sabin’s)Tager A.Tel-Aviv
|
|
Do you have an account?
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Learn more
Subscribe
- Access to all articles of the subscribed year(s) guaranteed for 5 years
- Unlimited re-access via Subscriber Login or MyKarger
- Unrestricted printing, no saving restrictions for personal use
Article / Publication Details
Received: September 04, 1974
Accepted: October 02, 1974
Published online: October 15, 2009
Issue release date: 1974
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: https://www.karger.com/DRM
Abstract
Twenty-three patients with recurrent Herpes simplex have been treated over a period of 4 years (1969–1972) with poliomyelitis vaccine (Sabin’s), given perorally in the dose of 4 drops once a month for 3 months only. In 74% of cases, this treatment resulted in full recovery with no relapse over a follow-up period of 1–4 years. No harmful side-effects whatsoever were noticed in any of the patients. On the basis of these results, it is concluded that the peroral administration of Sabin’s vaccine is a simple, safe and extremely effective method of treating recurrent Herpes simplex infection.
© 1974 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: September 04, 1974
Accepted: October 02, 1974
Published online: October 15, 2009
Issue release date: 1974
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: https://www.karger.com/DRM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission